Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2261)
All Articles published online
|
Mar 28, 2005 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Anatol P, Robert F, Danuta P. Effect of interferon alpha2b plus ribavirin treatment on selected growth factors in respect to inflammation and fibrosis in chronic hepatitis C. World J Gastroenterol 2005; 11(12): 1854-1858 [PMID: 15793880 DOI: 10.3748/wjg.v11.i12.1854] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i12/1854.htm |
| Number | Citing Articles |
| 1 |
Ove Bruland, Øystein Fluge, Lars A Akslen, Hans G Eiken, Johan R Lillehaug, Jan E Varhaug, Per M Knappskog. Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomas. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-425
|
| 2 |
Ki Tae Suk, Dae Yong Kim, Kyoung Min Sohn, Dong Joon Kim. . Advances in Clinical Chemistry 2013; 62: 33 doi: 10.1016/B978-0-12-800096-0.00002-0
|
| 3 |
Lai Wei, Yi-Hsiang Huang. Long-term outcomes in patients with chronic hepatitis C in the current era of direct-acting antiviral agents. Expert Review of Anti-infective Therapy 2019; 17(5): 311 doi: 10.1080/14787210.2019.1588112
|
| 4 |
Guillermo Cabrera Álvarez, Vicente Madrid-Marina, Ricardo Jimenez-Mendez, Angel Leon Buitimea, Margarita Bahena Román, Rudyard Cortez-Gomez, Jorge Reyes Esparza, Lourdes Rodríguez-Fragoso. Combined therapy with danazol, pegilated interferon, and ribavirin improves thrombocytopenia and liver injury in rats with fibrosis. Annals of Hepatology 2007; 6(4): 233 doi: 10.1016/S1665-2681(19)31904-0
|
| 5 |
Mohamed Essameldin Abdelgawad, Hamed El-zakzok, Mona Salah, Hatem A. El-mezayen. Diagnostic accuracy of hepatocyte growth factor, Fas/CD95 and Endostatin for non-invasive assessment of hepatic fibrosis in biopsy-proven hepatitis C virus patients. Infection, Genetics and Evolution 2020; 85: 104526 doi: 10.1016/j.meegid.2020.104526
|
| 6 |
Christina Groepper, Kerstin Rufinatscha, Nadja Schröder, Sabine Stindt, Christian Ehlting, Ute Albrecht, Hans H. Bock, Ralf Bartenschlager, Dieter Häussinger, Johannes G. Bode. HCV modifies EGF signalling and upregulates production of CXCR2 ligands: Role in inflammation and antiviral immune response. Journal of Hepatology 2018; 69(3): 594 doi: 10.1016/j.jhep.2018.04.005
|
| 7 |
Sadia Asim, Asim Mansha, Sana Aslam, Alina Shahzad. Study of Interactions Between 3-benzoyl-4-hydroxy-2-methyl-2H-1, 2-benzothiazine and Human DNA by Theoretical, Spectroscopic and Viscometric measurements. Journal of Fluorescence 2023; 33(1): 311 doi: 10.1007/s10895-022-03045-7
|
| 8 |
C Martín-González, L González-Navarrete, I Ribot-Hernández, V Vera-Delgado, J Alvisa-Negrín, A Godoy-Reyes, E Espelosín-Ortega, P Abreu-González, E González-Reimers. Platelet-Derived Growth Factor C in Alcoholics. Alcohol and Alcoholism 2020; 55(2): 157 doi: 10.1093/alcalc/agz094
|
| 9 |
Gergely Oswald, Kousi Alzoubi, Majed Abed, Florian Lang. Stimulation of Suicidal Erythrocyte Death by Ribavirin. Basic & Clinical Pharmacology & Toxicology 2014; 114(4): 311 doi: 10.1111/bcpt.12165
|
| 10 |
Mercedes Márquez-Coello, Ana Arizcorreta, María Rodríguez-Pardo, Francisco Illanes-Álvarez, Denisse Márquez, Sara Cuesta-Sancho, José-Antonio Girón-González. Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89370-6
|
| 11 |
Konstantin Shmagel, Evgeniya Saidakova. Advances in HIV and AIDS Control. 2018; doi: 10.5772/intechopen.76810
|
| 12 |
Robert Flisiak, Jerzy Jaroszewicz, Tadeusz W Łapiński, Iwona Flisiak, Danuta Prokopowiczi. Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-β1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C. World Journal of Gastroenterology 2005; 11(43): 6833-6838 doi: 10.3748/wjg.v11.i43.6833
|
| 13 |
Roba M. Talaat. Soluble Angiogenesis Factors in Sera of Egyptian Patients with Hepatitis C Virus Infection: Correlation with Disease Severity. Viral Immunology 2010; 23(2): 151 doi: 10.1089/vim.2009.0089
|
| 14 |
M. K. Jain, B. Adams‐Huet, D. Terekhova, L. E. Kushner, R. Bedimo, X. Li, M. Holodniy. Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co‐infected patients. Journal of Viral Hepatitis 2015; 22(1): 25 doi: 10.1111/jvh.12226
|
| 15 |
Abbie Connoy, JoLyn Turner, Marina Núñez. Levels of Serum Markers of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis C Virus Infection According to HIV Status and Antiretroviral Use. AIDS Research and Human Retroviruses 2011; 27(7): 719 doi: 10.1089/aid.2010.0224
|